Presenter: Suci Indriani

Hospital: National Cardiovascular Center Harapan Kita, Jakarta, Indonesia

Summary

A 62-year-old female developed left iliofemoral DVT 3 months post-kidney transplant. Mechanical thrombectomy (Angiojet) combined with apixaban achieved complete thrombus resolution without graft injury. This case underscores the need for personalized anticoagulation in transplant recipients.

Introduction

Kidney transplant recipients (KTRs) face a 4.6–12.5% risk of DVT due to hypercoagulability. Thrombectomy and anticoagulation must be tailored to preserve graft function.

Case analysis

Clinical Profile: Left leg swelling post-transplant; normal renal function.

Imaging: MR venography confirmed iliofemoral DVT.

Intervention: Angiojet thrombectomy + apixaban (5 mg bid) for 6 months.

•Outcome: Thrombus resolved without graft dysfunction.

Conclusion

1.Mechanical thrombectomy with DOACs (e.g., apixaban) is safe for KTRs with DVT. 

2.Regular monitoring of anticoagulation efficacy and renal function is essential.